NCT06246864

Brief Summary

While medical adhesives provide fixation of devices and catheters in neonatal intensive care, they can cause disruption of skin integrity when removed. Therefore, when detecting medical devices, it is important to choose products that will not harm babies' skin and to use different occlusive dressings (polymer foams, hydrogel dressings, hydrocolloid dressings). This study aims to compare the effectiveness of different types of patches (Hydrocolloid dressing and Hypoallergenic Flexible Patch) used in the detection of oragastric catheter (OG) in preterm babies hospitalized in the neonatal intensive care unit in preventing skin damage.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 30, 2024

Completed
6 days until next milestone

Study Start

First participant enrolled

February 5, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 7, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

February 9, 2024

Status Verified

February 1, 2024

Enrollment Period

7 months

First QC Date

January 30, 2024

Last Update Submit

February 7, 2024

Conditions

Keywords

prematureskin careHydrocolloid dressinghypoallergenic patch

Outcome Measures

Primary Outcomes (1)

  • Newborn Skin Condition Score

    NSCS allows evaluation of the newborn's skin condition. It evaluates skin dryness, redness and integrity, which are the basic characteristics of the newborn's skin. The scale consists of three parameters.

    The patch will be removed 24 hours after orogastric detection and a skin evaluation will be performed immediately.

Study Arms (2)

Hydrocolloid dressing group

EXPERIMENTAL

The premature baby's Oragastric tube will be fixed using a hydrocollaid dressing. Orogastric fixation will not be changed for 24 days. After 24 hours, the fixed patch will be removed using a silicone-based spray remover.

Other: Hydrocolloid dressing

Hypoallergenic Flexible Patch group

ACTIVE COMPARATOR

Oragastric tube of premature baby Hypoallergenic Flexible Patch will be detected using . Orogastric fixation will not be changed for 24 days. After 24 hours, the fixed patch will be removed using a silicone-based spray remover.

Other: Hypoallergenic Flexible

Interventions

After the oral gastric tube is placed on the premature baby and fixed with a Hydrocolloid dressing, the fixed patch will be removed after 24 hours using a silicone-based spray remover.

Hydrocolloid dressing group

After the oral gastric tube is placed on the premature baby and fixed with a hypoallergenic flexible patch, the fixed patch will be removed after 24 hours using a silicone-based spray remover.

Hypoallergenic Flexible Patch group

Eligibility Criteria

Age32 Weeks - 36 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • A newborn is a baby born between 32-36 weeks of gestation
  • No medical adhesive tape should be applied to the newborn's lips beforehand.
  • The newborn does not have any skin diseases
  • OG will be inserted into the newborn for the first time
  • Having a newborn receiving respiratory support with non-invasive mechanical ventilation, hood or free oxygen

You may not qualify if:

  • The newborn is not a baby born between 32-36 weeks of gestation
  • Applying medical adhesive tape on the newborn's lips beforehand
  • The newborn has any skin disease
  • OG has been inserted into the newborn before and detected.
  • Supporting and detecting the newborn's breathing by intubating it

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Premature Birth

Interventions

Bandages, Hydrocolloid

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

BandagesEquipment and Supplies

Central Study Contacts

Esra Tural Büyük, pHD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: randomized control experimental trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 30, 2024

First Posted

February 7, 2024

Study Start

February 5, 2024

Primary Completion

August 31, 2024

Study Completion

December 31, 2024

Last Updated

February 9, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share